Levocin is an external combination drug that has an antibacterial, antimicrobial, necrolytic, and local anesthetic effect that improves tissue regeneration.
Release form and composition
Levosin is produced in the form of an ointment for external use (40 g each in aluminum tubes, in a cardboard bundle 1 tube, 50 and 100 g each in dark glass jars, in a cardboard bundle 1 bank).
Active ingredients of the drug (in 1 g):
- Methyluracil - 40 mg;
- Sulfadimethoxine - 40 mg;
- Trimecain - 30 mg;
- Chloramphenicol - 10 mg.
Auxiliary component - polyethylene oxide.
Indications for use
Levosin is prescribed for the treatment of purulent wounds (including those infected with mixed microflora: difficult healing ulcers, wounds and burns) in the first phase of the wound process (purulent-necrotic).
Levocin is contraindicated in case of hypersensitivity to its components.
Clinical experience with the use of the drug during pregnancy and lactation is limited, so during these periods the agent can be prescribed only if the expected benefit to the mother outweighs the potential risks to the fetus / child.
Dosing and Administration
Levosin is intended for external use. Ointment is impregnated with sterile gauze napkins and loosely fill the wound with them.
If necessary, using a syringe through the drainage tube (catheter) means can be injected into the purulent cavity. In this case, it is heated to a temperature of 35-36 ºС.
Dressings are done daily until the wound is completely cleansed of purulent-necrotic masses.
Levocin can cause allergic reactions, manifested by skin rashes.
Before applying the dressing with Levosin's ointment, the wound needs to be treated: remove the necrotic tissue and rinse with hydrogen peroxide solution.
Information about the interaction of Levosin with other drugs is missing.
Terms and conditions of storage
Store at temperatures up to 20 ° C out of the reach of children and protected from light.
Shelf life - 2 years.